אוולטרה ®

País: Israel

Idioma: hebreo

Fuente: Ministry of Health

Ingredientes activos:

CLOFARABINE 1 MG/ML

Disponible desde:

SANOFI - AVENTIS ISRAEL LTD

Código ATC:

L01BB06

formulario farmacéutico:

CONCENTRATE FOR SOLUTION FOR INFUSION

Vía de administración:

I.V

Fabricado por:

GENZYME EUROPE B.V., NETHERLANDS

Grupo terapéutico:

CLOFARABINE

indicaciones terapéuticas:

Treatment of acute lymphoblastic leukaemia (ALL) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and who are about to undergo transplantation. Safety and efficacy have been assessed in studies of patients < or = 21 years old at initial diagnosis .

Fecha de autorización:

2012-04-01